1. EMA agrees to mandatory format for reporting of suspected ADRs

   News item 01 February 2020 Pages: 1 - 1

2. Highlights from the PRAC's January 2020 meeting

   News item 01 February 2020 Pages: 2 - 2

3. Implanon NXT: instructions updated to minimise implant-related risks

   News item 01 February 2020 Pages: 3 - 3

4. Nintedanib-related ischaemic colitis

   News item 01 February 2020 Pages: 4 - 4

5. FAERS reports: July-September 2019

   News item 01 February 2020 Pages: 5 - 5

6. ISMP: Top 10 medication errors and hazards for 2019

   News item 01 February 2020 Pages: 6 - 6

7. Long-term cardiopulmonary function impairment with trastuzumab

   Clinical study 01 February 2020 Pages: 7 - 7

8. Risk of thromboembolism or death with fibrinogen concentrate

   Clinical study 01 February 2020 Pages: 8 - 8

9. Rotavirus vaccination not associated with type 1 diabetes

   Clinical study 01 February 2020 Pages: 9 - 9

10. SGLT2 inhibitors: diabetic ketoacidosis in the surgical setting

    Clinical study 01 February 2020 Pages: 10 - 10

11. Other adverse reaction research

    News item 01 February 2020 Pages: 11 - 11

12. Acarbose

    Case report 01 February 2020 Pages: 12 - 12

13. Aciclovir

    Case report 01 February 2020 Pages: 13 - 13

14. Adalimumab

    Case report 01 February 2020 Pages: 14 - 14

15. Adalimumab/etanercept/infliximab

    Case report 01 February 2020 Pages: 15 - 15

16. Afatinib/gefitinib

    Case report 01 February 2020 Pages: 16 - 16

17. Albumin human

    Case report 01 February 2020 Pages: 17 - 17

18. Alcuronium-chloride/mivacurium-chloride/pancuronium-bromide

    Case report 01 February 2020 Pages: 18 - 18

19. Alectinib/ceritinib/crizotinib

    Case report 01 February 2020 Pages: 19 - 19

20. Alemtuzumab/biotin

    Case report 01 February 2020 Pages: 20 - 20

21. Alfacalcidol/phosphates

    Case report 01 February 2020 Pages: 21 - 21

22. Amikacin/linezolid

    Case report 01 February 2020 Pages: 22 - 22

23. Amiodarone

    Case report 01 February 2020 Pages: 23 - 23

24. Amiodarone

    Case report 01 February 2020 Pages: 24 - 24

25. Amiodarone

    Case report 01 February 2020 Pages: 25 - 25

26. Amiodarone/apixaban

    Case report 01 February 2020 Pages: 26 - 26

27. Anlotinib

    Case report 01 February 2020 Pages: 27 - 27

28. Antibacterials/antidepressants/opioid analgesics interaction

    Case report 01 February 2020 Pages: 28 - 28

29. Antineoplastics

    Case report 01 February 2020 Pages: 29 - 29

30. Antineoplastics

    Case report 01 February 2020 Pages: 30 - 30

31. Antineoplastics

    Case report 01 February 2020 Pages: 31 - 31

32. Antineoplastics

    Case report 01 February 2020 Pages: 32 - 32

33. Antineoplastics

    Case report 01 February 2020 Pages: 33 - 33

34. Antineoplastics

    Case report 01 February 2020 Pages: 34 - 34

35. Antineoplastics

    Case report 01 February 2020 Pages: 35 - 35

36. Antineoplastics/antifungals

    Case report 01 February 2020 Pages: 36 - 36

37. Antineoplastics/immunotherapies

    Case report 01 February 2020 Pages: 37 - 37

38. Antineoplastics/pertuzumab/trastuzumab

    Case report 01 February 2020 Pages: 38 - 38

39. Antineoplastics/semustine

    Case report 01 February 2020 Pages: 39 - 39

40. Antipsychotics

    Case report 01 February 2020 Pages: 40 - 40

41. Antiretroviral drugs

    Case report 01 February 2020 Pages: 41 - 41

42. Antithymocyte-globulin

    Case report 01 February 2020 Pages: 42 - 42

43. Antituberculars

    Case report 01 February 2020 Pages: 43 - 43

44. Antivirals/lidocaine interaction

    Case report 01 February 2020 Pages: 44 - 44

45. Apixaban/dabigatran etexilate/rivaroxaban

    Case report 01 February 2020 Pages: 45 - 45

46. Asfotase α

    Case report 01 February 2020 Pages: 46 - 46

47. Asparaginase

    Case report 01 February 2020 Pages: 47 - 47

48. Aspirin/clopidogrel

    Case report 01 February 2020 Pages: 48 - 48

49. Aspirin/ticagrelor

    Case report 01 February 2020 Pages: 49 - 49

50. Atezolizumab

    Case report 01 February 2020 Pages: 50 - 50